A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Sánchez-Arráez J.
Grupos
Abstract
We read with interest the article by Recalcati et al. about the report of cutaneous manifestations in COVID-19 patients. We would like to highlight that some potentially severe manifestations in these patients are not directly related to the coronavirus but to the medications administered.
Datos de la publicación
- ISSN/ISSNe:
- 0926-9959, 1468-3083
- Tipo:
- Letter
- Páginas:
- 537-539
- DOI:
- 10.1111/jdv.16664
- PubMed:
- 32455478
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 1,655 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY WILEY
Citas Recibidas en Web of Science: 11
Documentos
- No hay documentos
Filiaciones
Keywords
- Acute Generalized Exanthematous Pustulosis; Adrenal Cortex Hormones; Biopsy, Needle; Cephalosporins; Clinical Laboratory Techniques; Coronavirus Infections; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Immunohistochemistry; Middle Aged; Obesity, Morbid; Pandemics; Pneumonia, Viral; Severe Acute Respiratory Syndrome; Severity of Illness Index; Treatment Outcome; azithromycin; beta interferon; C reactive protein; cefditoren; ceftriaxone; hydroxychloroquine; lopinavir plus ritonavir; methylprednisolone; prednisone; tocilizumab; cefditoren; cephalosporin derivative; corticosteroid; acute generalized exanthematous pustulosis; adult; adverse event; artificial ventilation; asymptomatic disease; blood analysis; case report; clinical article; coronavirus disease 2019; disease severity; dose response; drug dose reduction; extubation; female; histopathology; human; human tissue; intensive care; Letter; middle aged; neutrophilia; obesity; pandemic; physical examination; priority jou
Portal de investigación